Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NARF | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
mRNA | COPA | CTRPv2 | pan-cancer | AAC | -0.14 | 7e-05 |
mRNA | SMAD4 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
mRNA | UCHL5 | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-05 |
mRNA | NDUFS8 | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-05 |
mRNA | LGALS9 | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-05 |
mRNA | MRPL41 | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-05 |
mRNA | LDB1 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
mRNA | GRAP2 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
mRNA | FLAD1 | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-05 |